| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.07 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.08 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.08 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.08 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.056 | 0.08 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.062 | 0.08 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.08 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | -0.054 | 0.08 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.08 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.09 |